ADVANCED HEALTH LIMITED - Update to the Strategic Review of Advanced Health

Update to the Strategic Review of Advanced Health

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “AVL”)
ISIN Code: ZAE000189049        JSE Code: AVL

UPDATE TO THE STRATEGIC REVIEW OF ADVANCED HEALTH

Shareholders are referred to the announcements released by AVL on 15 June 2022 and 25 August 2022, which
advised that the strategic review of the Advanced Health group is ongoing. AVL confirmed that it received
inbound approaches from several parties interested in a potential acquisition of its shares within PresMed
Australia, the Australian subsidiary of AVL.

The appointed AVL sub-committee is still evaluating these approaches through a formalised process with
interested parties, with the assistance of its Australian advisors, Monash Advisory. The process is ongoing
and there are still no assurances that the AVL board will decide to pursue, nor that any transaction or
transactions will materialise. Shareholders do not need to take any action in relation to this. AVL will continue
to keep shareholders informed about the progress and outcomes of the current evaluation process.

Pretoria
10 November 2022

Designated Advisor
Grindrod Bank Limited

Date: 10-11-2022 02:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.